IP Library Granted Patent US 6,894,025
Granted Patent B2
US 6,894,025 · App. 10/647,621 · Granted May 17, 2005

Biologically active molecules having thiol moiety conjugated to polymers containing ethyl sulfone moiety

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,894,025
App. No.
10/647,621
Granted
May 17, 2005
Kind
B2
Abstract

A poly(ethylene glycol) derivative is disclosed that is activated with a sulfone moiety for selective attachment to thiol moieties on molecules and surfaces. The activated PEG is water soluble, hydrolytically stable for extended periods, and forms hydrolytically stable linkages with thiol moieties. The linkages generally are not reversible in reducing environments. The PEG derivative is useful for modifying the characteristics of substances including modifying biologically active molecules and surfaces for biocompatibility. Methods for synthesizing the active PEG and for preparing conjugates of the active PEG and other substances, including biologically active substances, are also disclosed.

Claims (12)

1. A hydrolytically stable, biologically active conjugate that is the reaction product of a biologically active molecule having a reactive thiol moiety and a water-soluble polymer having an active ethyl sulfone moiety having a reactive site located at the second carbon from the sulfone group and wherein said sulfone moiety forms a linkage with said reactive thiol moiety of said biologically active molecule to form said conjugate.

2. The conjugate of claim 1 wherein said biologically active molecule is a protein and said reactive thiol moiety is contained within a cysteine moiety of said protein.

3. The conjugate of claim 1 wherein said water soluble polymer is selected from the group consisting of poly(alkylene oxides), poly(oxyethylated polyols), and poly(olefinic alcohols).

4. The conjugate of claim 1 wherein said water soluble polymer includes a second active moiety, which may be the same or different from said active sulfone moiety, and wherein said second active moiety forms a linkage with a second biologically active molecule.

5. The conjugate of claim 1 wherein said biologically active moiety is selected from the group consisting of proteins, pharmaceuticals, cells, vitamins, and combinations thereof.

6. The conjugate of claim 1 wherein said ethyl sulfone moiety is a haloethyl sulfone.

7. The conjugate of claim 1 wherein said water soluble polymer is poly(ethylene glycol).

8. A biologically active conjugate that is the reaction product of an activated water soluble polymer having at least one active ethyl sulfone moiety that is selective for reaction with thiol moieties and at least one other moiety that is selective for reaction with amino moieties; a first protein having a thiol moiety wherein said thiol moiety forms a hydrolytically stable linkage with said ethyl sulfone moiety on said polymer; and a second protein having an amino moiety wherein said amino moiety forms a linkage with paid other moiety on said polymer.

9. The conjugate of claim 8 wherein said first protein contains cysteine units and said second protein contains lysine units.

10. The conjugate of claim 8 wherein said water soluble polymer is selected from the group consisting of poly(alkylene oxides), poly(oxyethylated polyols), and poly(olefinic alcohols).

11. The conjugate of claim 8 wherein said conjugate is a dumbbell structure.

12. A hydrolytically stable biologically active conjugate that is the reaction product of biologically active molecules, each having a reactive thiol moiety, and a water soluble polymer having at least two active ethyl sulfone moieties, each active ethyl sulfone moiety having a reactive site located at the second carbon from the sulfone group and wherein said sulfone moieties form a linkage with said reactive thiol moieties of said biologically active molecules to form said conjugate.

Assignments (3)
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →